This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.63% per year. These returns cover a period from January 1, 1988 through December 2, 2019. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tenet Healthcare (THC) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
Tenet Healthcare (THC) concluded the recent trading session at $134.42, signifying a -0.01% move from its prior day's close.
Should You Invest in Tenet (THC) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Tenet (THC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
4 Sector ETFs & Stocks to Benefit Despite Cooling Inflation
by Sanghamitra Saha
These sector ETFs and stocks may win amid cooling inflation.
Tenet Healthcare (THC) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
In the most recent trading session, Tenet Healthcare (THC) closed at $127.63, indicating a -1.27% shift from the previous trading day.
Why Tenet (THC) Could Beat Earnings Estimates Again
by Zacks Equity Research
Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Community Health Drops 16.4% in 6 Months: Should You Hold or Fold?
by Zacks Equity Research
CYH's declining volumes and industry pressures raise concerns about its outlook despite efforts like strategic divestitures
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Tenet Healthcare (THC) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Tenet Healthcare (THC) concluded the recent trading session at $130.21, signifying a +1.09% move from its prior day's close.
Universal Health Stock Trading at Attractive Valuation: Time to Buy?
by Kaibalya Pravo Dey
With UHS stock trading at a discount, we examine its growth drivers and challenges to determine if it presents a strong investment opportunity for investors at this time.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Buy Tenet Healthcare Stock Now at Cheaper Valuation?
by Kaibalya Pravo Dey
As occupancy levels rise and resource utilization grows, THC's operating costs are expected to continue increasing.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet Healthcare (THC) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
The latest trading day saw Tenet Healthcare (THC) settling at $125.42, representing a -1.99% change from its previous close.
Wall Street Top Picks: 3 Healthcare Stocks Analysts Are Bullish About
by Kaibalya Pravo Dey
The long-term outlook for the healthcare sector remains favorable, with profits expected to rise; analysts are bullish on THC, EHC and ENSG stocks.
Tenet (THC) Upgraded to Buy: Here's Why
by Zacks Equity Research
Tenet (THC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
HCA Healthcare Stock Trades at Premium: Time to Buy or Hold?
by Kaibalya Pravo Dey
HCA's strong cash-generating abilities are expected to improve its financial position.
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tenet Healthcare (THC) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
In the most recent trading session, Tenet Healthcare (THC) closed at $129.64, indicating a +0.14% shift from the previous trading day.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Buy These 4 Stocks With Attractive Interest Coverage Ratio
by Sumit Singh
STRL, LDOS, THC & AMZN's impressive interest coverage ratios highlight that these companies can withstand financial hardships.